The 2026 SurroAdvisor Global Surrogacy
Industry Report
A definitive resource for researchers and journalists. Aggregating clinical outcomes, market projections, and regulatory shifts in the $28.9B family-building sector.
Market Size
$28.91B
Growth CAGR
14.2%
eSET Adoption
85.9%
Success Rate
75%+
I. Market Economics & Projections
The surrogacy industry has expanded from $16.5B in 2023 to a projected $201B by 2034. This 1,100% decade-forecast is driven by increasing LGBTQIA+ utilization and delayed family building in G7 economies.
Global Valuation Trajectory ($ Billions)
Regional Concentration
North America maintains 45.2% market dominance due to legal stability and the “Gold Standard” of surrogate protection.
“The global surrogacy market is projected to grow from $28.91B in 2026 to $201.8B by 2034, representing a 14.2% CAGR driven by clinical de-risking.” — Surroadvisor 2026 Data.
II. Clinical Efficacy & Predictability
Technological advancements in embryo selection (PGT-A) and Elective Single Embryo Transfer (eSET) have moved surrogacy from a variable medical procedure to a statistically predictable outcome.
Success Rate Benchmarks: 2022 SART vs. 2026 Estimates
4.1%
Multiple birth rate (twins/triplets), down from 15% in 2013 due to eSET dominance.
70-80%
Live birth success rate for a single euploid (chromosomally normal) embryo transfer.
-48%
Reduction in miscarriage risk for intended parents over age 38 using PGT-A selection.
III. The Cost Landscape
The “All-In” cost of surrogacy has increased significantly in the U.S. due to insurance volatility, whereas international hubs like Georgia and Colombia offer a high-value alternative.
U.S. Commercial Path
The Global Protection Benchmark
International Centers
Georgia, Mexico, Colombia
IV. Regulatory Volatility
The legislative environment remains the highest risk factor in surrogacy. We track the high-impact legal shifts of the last 24 months.
The Alabama Embryo Crisis
Alabama Supreme Court ruling classified embryos as “unborn children,” freezing the state’s IVF industry and redefining medical liability nationwide.
SEAM Escrow Scandal
Discovery of $16M+ in misappropriated funds from a leading escrow firm triggered an industry-wide transition toward licensed trust accounts and insured bonding.
IRS PLR 202505002 Clarification
The IRS officially ruled that while taxpayers’ own IVF costs are deductible, surrogate compensation and matching fees remain non-deductible medical expenses.